| |   | | | | By Ed Silverman APStock More than a dozen major drugmakers have curtailed the discounts on medicines offered through the 340B program. Read More | | By Ed Silverman Adobe A new analysis finds that after accounting for inflation, wholesale prices of brand-name drugs fell by 2.3% in the last quarter of 2021. Read More | | By Lev Facher Rich Pedroncell/AP Xavier Becerra is the focus of a frenzied, last-minute lobbying effort from top lawmakers and a key Nancy Pelosi aide on ARPA-H. Read More | | Sponsor content by STAT Events Last Chance: The STAT Breakthrough Science Summit This Thursday, leaders from Pfizer, Bristol Myers Squibb, and Merck will take the stage to discuss what’s next for their organizations. We’ll also explore the future of CRISPR and unpack the feasibility of pig-to-human transplants. There’s so much more, so check out statnews.com/summit to see the full agenda and find more information about our featured speakers. Then, get your ticket to join us! | | By Bob Herman and Tara Bannow Jim Mone/AP UnitedHealth Group’s proposed $5.4 billion buyout of home health provider LHC Group shows insurers' ravenous appetite for the sector. Read More | | By Andrew Joseph Eugene Hoshiko/AP Those 50 and up are now eligible for another shot of either the Pfizer-BioNTech and Moderna mRNA vaccines four months after their last dose. Read More | |
No comments